University Pathologists
University Pathologists was paid $1.35M by Medicaid between Jan 2018 and Dec 2024, across 17 billing codes. Its largest line is 87491, Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe — 19% of everything it billed.
HOUSTON, TX 77030
Next to other Clinical Medical Laboratory providers in Texas
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,240 | $23K | |
| 2019 | 1,720 | $33K | |
| 2020 | 7,965 | $197K | |
| 2021 | 26,140 | $256K | |
| 2022 | 27,849 | $233K | |
| 2023 | 25,307 | $299K | |
| 2024incomplete | 27,581 | $306K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 19% | 20,130 | 19,418 | $256K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 19% | 20,076 | 19,373 | $253K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 11% | 3,452 | 3,179 | $150K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 8.3% | 11,641 | 11,273 | $112K |
| 87480 | 7.9% | 15,027 | 14,407 | $107K | |
| 87660 | 7.6% | 14,480 | 13,905 | $102K | |
| 87510 | 6.8% | 14,501 | 13,930 | $92K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 6.8% | 7,522 | 7,245 | $92K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 4.3% | 1,385 | 1,298 | $58K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 2.4% | 1,701 | 1,654 | $32K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 2.1% | 1,933 | 1,876 | $28K |
| 88141 | 2.0% | 3,065 | 2,966 | $27K |
5 more codes
| 87563 | 1.4% | 1,211 | $20K | |
| 87625 | <1% | 758 | $11K | |
| 88142 | <1% | 835 | $7K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 17 | $107.96 |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 0% | 68 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Mainehealth | Rockport, ME | $31.54M |
| Mainehealth | Farmington, ME | $16.71M |
| Mainehealth | Norway, ME | $10.00M |
| Mainehealth | Norway, ME | $9.84M |
| Mainehealth | Damariscotta, ME | $9.60M |
| Mainehealth | Belfast, ME | $5.33M |
| Mainehealth | Norway, ME | $5.06M |
| Mainehealth | Livermore Falls, ME | $3.15M |
| Mainehealth | Boothbay Harbor, ME | $2.90M |
| Mainehealth | Damariscotta, ME | $2.62M |
| Mainehealth | Farmington, ME | $2.36M |
| Mainehealth | Farmington, ME | $435K |
| P R Hematology Oncology Group INC | Bayamon, PR | $69K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.